76 related articles for article (PubMed ID: 9401829)
21. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
22. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
Min B; Cios D; Kluger J; White CM
Pharmacotherapy; 2005 Dec; 25(12):1719-24. PubMed ID: 16305290
[TBL] [Abstract][Full Text] [Related]
23. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
Lasseter KC; Shaughnessy L; Cummings D; Pezzullo JC; Wargin W; Gagnon R; Oliva J; Kosutic G
J Clin Pharmacol; 2008 Feb; 48(2):193-202. PubMed ID: 18199894
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
25. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
[TBL] [Abstract][Full Text] [Related]
26. A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin.
Mulchahey JJ; Goldwater DR; Zemlan FP
Life Sci; 2004 Aug; 75(15):1843-56. PubMed ID: 15302228
[TBL] [Abstract][Full Text] [Related]
27. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
[TBL] [Abstract][Full Text] [Related]
28. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.
Diener HC; Cortens M; Ford G; Grotta J; Hacke W; Kaste M; Koudstaal PJ; Wessel T
Stroke; 2000 Nov; 31(11):2543-51. PubMed ID: 11062273
[TBL] [Abstract][Full Text] [Related]
29. Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects.
Wemer J; Cheng YF; Nilsson D; Reinholdsson I; Fransson B; Lanbeck Vallén K; Nyman L; Eriksson C; Björck S; Schulman S
Curr Med Res Opin; 2006 Sep; 22(9):1813-23. PubMed ID: 16968585
[TBL] [Abstract][Full Text] [Related]
30. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
31. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
Diener HC; Hacke W; Hennerici M; Rådberg J; Hantson L; De Keyser J
Stroke; 1996 Jan; 27(1):76-81. PubMed ID: 8553408
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
33. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
[TBL] [Abstract][Full Text] [Related]
34. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.
Miceli JJ; Wilner KD; Swan SK; Tensfeldt TG
J Clin Pharmacol; 2005 Jun; 45(6):620-30. PubMed ID: 15901743
[TBL] [Abstract][Full Text] [Related]
36. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
38. Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-beta inhibitor, in healthy subjects.
Welch PA; Sinha VP; Cleverly AL; Darstein C; Flanagan SD; Musib LC
J Clin Pharmacol; 2007 Sep; 47(9):1138-51. PubMed ID: 17766700
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers.
Hunt TL; Cramer M; Shah A; Stewart W; Benedict CR; Hahne WF
J Clin Pharmacol; 1995 Jul; 35(7):705-12. PubMed ID: 7560251
[TBL] [Abstract][Full Text] [Related]
40. Local and systemic tolerability of suprofen. Experience with intravenous administration and infusion in healthy volunteers (1st comm.).
Michos N; Zulliger HW; Fenzl E
Arzneimittelforschung; 1985; 35(4):745-8. PubMed ID: 4015741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
